Parison Amy (CIK 2063082) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell EDIT (453 shares), Sell EDIT (678 shares), Sell EDIT (464 shares), Sell EDIT (474 shares), Sell EDIT (461 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 453 | $1,376 |
| 2026-08-05 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 678 | $1,749 |
| 2026-06-05 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 464 | $1,253 |
| 2026-03-04 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 474 | $957 |
| 2025-12-04 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 461 | $991 |
| 2025-09-04 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 458 | $1,191 |
| 2025-08-08 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 679 | $1,752 |
| 2025-06-04 | Editas Medicine, Inc. (EDIT) | SVP, Chief Financial Officer | Sell | 446 | $767 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04